Skip links

Disciplined Agile – A toolkit for Organizational Agility

Jump To Section

In today’s market conditions, organizations must be able to adapt to evolving consumer needs at a crazy fast pace, stay competitive, and should be able to scale.

Business Transformation: Disciplined Agile’s Lean Approach

In today’s market conditions, organizations must be able to adapt to evolving consumer needs at a crazy fast pace, stay competitive, should be able to scale. We need to build awesome teams that work nimbly on small increments, leveraging technology as a strategic enabler. With the COVID situation this year, distributed teams have become the new normal. Now more than ever organizations have a compelling need to transform digitally. Agile has always led any successful transformation due to its proven effectiveness on teams. Teams are continuously in pursuit of a framework that brings predictability on delivery, managing cross dependencies with focused business objectives.

Across industries, teams have adopted various agile frameworks based on their need and available talent. This has helped engineering teams to be responsive to change and be customer-centric. An organization is nothing but a collection of teams across different departments. True agility would require us to apply agile values and practices across different departments like HR, Finance, and so on. Most of these frameworks lose relevance if we try to extend them beyond software development to other faculties. Thus emerges Disciplined Agile, a new evolved approach on lean based thinking and process patterns that improves an organization’s ability to achieve business agility.

Business Agility

Agile Freedom: Disciplined Agile’s Toolkit Liberates Work

Disciplined Agile is a hybrid toolkit that is built upon other process frameworks like SCRUM, Kanban, agile modelling, and so on. Disciplined Agile delivery adopts practices and strategies from existing sources and provides guidance on how to apply them as tools. DA Delivery supports multiple life cycles for solution delivery. Leading development organizations have started adopting DA as a supplement to augment existing Agile practice be it SCRUM, SAFe, or Kanban. (Reference: https://bit.ly/2EmtIx0)

DA has also addressed the larger challenge of recommended Agile practices and strategies that can be adopted contextually across the enterprise onto Marketing, Sales, HR, Legal, Business Operations, and Procurement. They are termed as “process blade” in DA. It is a goal-driven, scalable, and enterprise aware approach. Each process blade addresses a specific capability and like a blade server can be applied and removed as and when required.

The second challenge that Disciplined Agile solves is that when teams are adopting a particular framework, sometimes they feel constrained by the boundaries of that framework. It is termed as “method prison” and signifies there is no flexibility to pick up the best practices from other methodologies. But the moment you start looking at all these frameworks as a toolkit that can help you uncover what suits you best and find your “Way of working”, DA takes a one-up advantage in the Agile landscape.

Last but not the least, Disciplined Agile adopts the practice “Kaizen” of making small, incremental changes to bring productive efficiency into the system. This is called Guided Continuous Improvement in DA that is derived from lean manufacturing and Six sigma.

Courtesy: Image Credit – Project Management Institute

Syed Nazir Razik

Syed Nazir Razik

Latest Reads

Subscribe

Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes